Literature DB >> 14731124

Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit.

Paul J Gow1, Robert M Jones, Jacqui L Dobson, Peter W Angus.   

Abstract

BACKGROUND AND AIMS: The primary aims were to identify the incidence, etiology and outcome of all adult cases of fulminant hepatic failure (FHF) presenting to the Victorian Liver Transplant Unit over the 14 year period since the Unit was established in 1988.
METHODS: The database of the Unit was used to identify all adult patients (>16 years) who were referred to the Austin and Repatriation Medical Center in Melbourne with FHF between 1988 and 2001. The Austin and Repatriation Medical Center is the sole provider of adult liver transplantation services for the states of Victoria and Tasmania.
RESULTS: 80 patients (64 female, 14 male) with FHF were referred, at a rate of approximately one case per million population per year. The mean age was 37.6 +/- 13.7 years. Most cases were due to either paracetamol poisoning n = 29 (36%) or non-A non-B (idiopathic) hepatitis n = 27 (34%). Thirty-five patients were listed for transplantation, of which 26 underwent the procedure (77% of transplantation patients currently alive). Nine patients were listed for transplantation but did not undergo the procedure, eight died before a donor became available and one recovered. Of the 30 patients who survived without transplantation, 20 cases were due to paracetamol poisoning.
CONCLUSIONS: Liver transplantation has had a major impact on survival of patients with FHF, most significantly in patients with FHF due to causes other than paracetamol poisoning, in whom survival without transplantation is uncommon. Survival in those who undergo transplantation for FHF is excellent, but a significant percentage of patients listed for transplantation die before a donor organ becomes available.

Entities:  

Mesh:

Year:  2004        PMID: 14731124     DOI: 10.1111/j.1440-1746.2004.03273.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  15 in total

Review 1.  Approach to clinical syndrome of jaundice and encephalopathy in tropics.

Authors:  Anil C Anand; Hitendra K Garg
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

Review 2.  Clinical presentations of Wilson disease.

Authors:  Samuel Shribman; Thomas T Warner; James S Dooley
Journal:  Ann Transl Med       Date:  2019-04

3.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.

Authors:  Mitchell R McGill; Matthew R Sharpe; C David Williams; Mohammad Taha; Steven C Curry; Hartmut Jaeschke
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 4.  Liver Failure due to Acute Viral Hepatitis (A-E).

Authors:  Paul Manka; Jens Verheyen; Guido Gerken; Ali Canbay
Journal:  Visc Med       Date:  2016-04-07

Review 5.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

Review 6.  Optimizing management in autoimmune hepatitis with liver failure at initial presentation.

Authors:  Jonathan R Potts; Sumita Verma
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

7.  Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity.

Authors:  Mitchell R McGill; C David Williams; Yuchao Xie; Anup Ramachandran; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-23       Impact factor: 4.219

Review 8.  Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Pharm Res       Date:  2013-03-06       Impact factor: 4.200

Review 9.  Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.

Authors:  Anil C Anand; Bhaskar Nandi; Subrat K Acharya; Anil Arora; Sethu Babu; Yogesh Batra; Yogesh K Chawla; Abhijit Chowdhury; Ashok Chaoudhuri; Eapen C Eapen; Harshad Devarbhavi; RadhaKrishan Dhiman; Siddhartha Datta Gupta; Ajay Duseja; Dinesh Jothimani; Dharmesh Kapoor; Premashish Kar; Mohamad S Khuroo; Ashish Kumar; Kaushal Madan; Bipadabhanjan Mallick; Rakhi Maiwall; Neelam Mohan; Aabha Nagral; Preetam Nath; Sarat C Panigrahi; Ankush Pawar; Cyriac A Philips; Dibyalochan Prahraj; Pankaj Puri; Amit Rastogi; Vivek A Saraswat; Sanjiv Saigal; Akash Shukla; Shivaram P Singh; Thomas Verghese; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-04-28

10.  Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications.

Authors:  Mitchell R McGill; Margitta Lebofsky; Hye-Ryun K Norris; Matthew H Slawson; Mary Lynn Bajt; Yuchao Xie; C David Williams; Diana G Wilkins; Douglas E Rollins; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-06       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.